Menu
Back to User profile » Dr Jill Ohar
Papers published by Dr Jill Ohar:
Low Peak Inspiratory Flow Rates are Common Among COPD Inpatients and are Associated with Increased Healthcare Resource Utilization: A Retrospective Cohort Study
Clark B, Wells BJ, Saha AK, Franchino-Elder J, Shaikh A, Donato BMK, Ohar JA
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1483-1494
Published Date: 29 June 2022
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
Ohar JA, Ferguson GT, Mahler DA, Drummond MB, Dhand R, Pleasants RA, Anzueto A, Halpin DMG, Price DB, Drescher GS, Hoy HM, Haughney J, Hess MW, Usmani OS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:79-92
Published Date: 6 January 2022
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]
Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1347-1348
Published Date: 14 May 2021
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:995-1004
Published Date: 6 May 2020
Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD
Ghosh S, Pleasants RA, Ohar JA, Donohue JF, Drummond MB
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:585-595
Published Date: 1 March 2019
Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of the GEM1 and GEM2 12-week studies
Ohar JA, Bowling A, Goodin T, Price B, Ozol-Godfrey A, Sharma S, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:461-470
Published Date: 19 February 2019
Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4
Ohar J, Tosiello R, Goodin T, Sanjar S
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:27-37
Published Date: 18 December 2018
Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA
Cohen J, Miles MC, Donohue JF, Ohar JA
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:785-797
Published Date: 15 April 2016
Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history
Liu Y, Pleasants RA, Croft JB, Wheaton AG, Heidari K, Malarcher AM, Ohar JA, Kraft M, Mannino DM, Strange C
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1409-1416
Published Date: 21 July 2015